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Abstract
Background: The increased susceptibility to latent tuberculosis infection (LTBI) of HIV-1-infected persons represents
a challenge in TB epidemic control. However few studies have evaluated LTBI predictors in a generalized HIV/TB epidemic
setting.
Methods: The study recruited 335 HIV-infected participants from Khayelitsha, Cape Town between February 2008 and
November 2010. Tuberculin skin tests and interferon-gamma release assays were performed on all participants and active
TB excluded using a symptom screen, TB microscopy and culture.
Results: LTBI prevalence was 52.7% and 61.2% (TST and IGRA respectively). Being a recent TB contact (OR 2.07; 95% C.I.
1.15–3.69) was associated with TST positivity. Participants with a CD4.200 had a two-fold higher risk of IGRA positivity
compared to those with CD4 counts,200 (OR 2.07; 95% C.I. 0.99–4.34). There was also a 19% increase in IGRA positivity risk
for every additional year of schooling and a strong association between years of schooling and employment (p = 0.0004). A
decreased risk of IGRA positivity was observed in persons with a BCG scar (OR 0.46; 95% C.I. 0.31–0.69) and in smokers (OR
0.47; 95% C.I. 0.23–0.96).
Conclusion: We report the novel findings of a decreased risk of IGRA positivity in HIV-infected smokers possibly due to
decreased interferon production, and in the persons with a BCG scar suggesting a protective role for BCG in this population.
We also found an increased risk of TST positivity in employed persons, possibly due to ongoing transmission in public
modes of transport.
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Introduction
A high prevalence of latent tuberculosis infection (LTBI)
globally means there remains a pool of M.tb. infection from which
new cases will arise. HIV-1 (HIV)-infected persons are often over-
represented among TB cases, as the risk of re-infection and
reactivation are greater.
Detection of LTBI enables identification of HIV-infected
persons who would benefit from preventive therapy. However,
in high HIV/TB prevalence, low-income settings, screening the
general population for LTBI poses significant operational and
economic challenges. A greater understanding of risk factors for
infection could enable more accurate identification of high-risk
persons who might benefit from preventive therapy. A better
comprehension of factors that increase the risk of TB infection
could also facilitate developing other interventions to attenuate this
risk.
To this end, studies have examined the prevalence of, and risk
factors for LTBI in health care workers (HCW), who experience
a higher risk of TB exposure than the general population [1–11].
However, HCW do not represent the population of HIV-infected
adults. The aim of this study was to describe the prevalence of
LTBI and to evaluate associated risk factors in HIV-infected adults
in a high HIV/TB burden setting.
Methods
Participants
From February 2008 to November 2010, consecutive patients
attending the HIV wellness clinic at Khayelitsha day hospital were
informed about the study on weekday mornings, when the clinic
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was busiest, and were invited to participate. Adults aged over 18
years with no signs and symptoms of TB disease were potentially
eligible for inclusion. Active TB was excluded by induced sputum
sent for TB microscopy and culture. In addition, all patients with
a positive tuberculin skin test had chest radiography performed.
During the study period 335 HIV-infected persons with no signs
and symptoms of TB and from whom sputum samples could be
collected, were identified. Written informed consent was obtained
from all participants, and the study was approved by the
University of Cape Town Faculty of Health Sciences Research
Ethics Committee.
Tuberculin Skin Test
A Mantoux skin test was performed in enrolled patients using 2
tuberculin units (TU) of purified protein derivative (PPD) of
tuberculin RT23 injected intradermally into the volar aspect of the
forearm. This was read 48–72 hours after administration by
measuring the induration transverse diameter. A positive TST was
defined as $5 mm.
Interferon Gamma Release Assay (IGRA)
A 7-day in-house IGRA assay was performed as described
elsewhere [12]. Briefly, whole blood was diluted 1:10 final
concentration in RPMI 1640 medium containing 1% L-Gluta-
mine and added to a 24-well flat bottom plate at 1 ml/well.
Antigens (ESAT-6, CFP-10 (Proteix, Czech Republic) and ESAT-
6/CFP-10 Fusion Protein (Leiden University Medical Centre,
Netherlands)) were added at a final concentration of 5 mg/ml.
After mixing, the plate was incubated at 37uC with 5% CO2 for 7
days. The supernatants were then harvested into sample storage
tubes and IFN-c ELISA performed [13]. The antigen-specific cut-
off values were chosen using the QuantiFERON Gold-in-Tube
(QFT-GIT) test as an arbitrary gold standard. The lowest cut-off
values that provided 100% sensitivity at the highest likelihood ratio
were chosen.
Statistical Analysis
Baseline characteristics were compared using simple propor-
tions. Risk factors associated with TST and IGRA positivity were
analysed using multivariable logistic regression. The model was
built manually starting with an empty model. Nested models were
compared using the likelihood ratio test. The Akaike’s Information
Criterion (AIC) was used to compare non-nested models with
a significantly lower AIC (.10%) indicating an improved model.
Significance testing was done using a combination of two-sided p-
values (p,0.05), 95% confidence intervals and p-value function
graphs. All data were analysed using STATA 10.0 (StataCorp,
College Station, TX, USA).
Results
We recruited 335 HIV-infected persons. Compared to TST
negative, TST positive participants were more likely to be
employed (36.7% versus 29.3%), and were more likely to report
contact with a TB case within the preceding 12 months (25.3%
versus 14.1%) (Table 1). There was no difference in the median
CD4 count between TST negative and positive persons (CD4 337
(IQR 226–337) versus 362 (IQR 253–519); Spearman’s correla-
tion coefficient r = 0.082; p = 0.148)). However, the median overall
CD4 count of 345 in this study population reflects a lack of severe
immunosuppression and could explain the lack of an association
between CD4 count and TST positivity. Alternatively, the study
may also have been insufficiently powered to detect this
association.
Prevalence of TST and IGRA Positivity
We examined the LTBI prevalence using the TST and found
a prevalence of 52.7% (95% C.I. 47.3%–58.3%). Using the IGRA,
the effect of immunosuppression was less marked with a higher
prevalence of IGRA positivity compared to TST positivity (61.2%
(95% C.I. 55.7%–66.4%).
Factors Associated with TB Infection
A recent contact with a TB case in the preceding 12 months was
the only significant variable associated with TST positivity in the
multivariable regression model (OR 2.07; 95% C.I. 1.15–3.69).
The inclusion of additional variables into this model did not
significantly improve the fit of the model to the data.
The presence of a BCG scar was associated with a reduction in
risk of IGRA positivity (OR 0.59; 95% C.I. 0.35–1.02) (Table 2).
The overall median ESAT-6 (277 (IQR 0–1414) vs. 578 (IQR
166–2420)), CFP-10 (110 (IQR 0–893) vs. 305 (IQR 44–1193))
and fusion protein (358 (IQR 0–1745) vs. 440 (IQR 105–2122))
responses (pg/ml) were lower in persons with a BCG scar
compared to those without a scar respectively (Figure 1). In
addition, there was an increase in the risk of IGRA positivity for
every additional year of schooling (OR 1.19; 95% C.I. 1.05–1.34).
Of note, there was a strong correlation between educational
attainment and employment status (Pearson chi2 p = 0.005).
The odds of being IGRA positive were 53% lower in smokers
compared to non-smokers. We considered misclassification bias as
a potential reason for this finding and performed sensitivity
analysis, creating a new smoking variable by re-classifying ex-
smokers as current smokers. This resulted in an increase in the
proportion of female smokers from 24% to 28%. However, this
did not alter the final model results. We also examined the
interaction between smoking and gender, and found a statistically
significant interaction variable suggesting that the effect of
smoking on LTBI risk is different for the two gender groups, with
a higher risk of IGRA positivity in male smokers (interaction
variable OR 3.12; p= 0.038). We also compared the mitogen
responses between smokers and non-smokers and although lower
in smokers, there was no statistically significant difference in the
median response to mitogen in smokers (11338 (IQR 5611–27606)
pg/ml) versus non-smokers (12832 (IQR 3873–34179) pg/ml).
The odds of being IGRA positive were 2-fold higher in HIV-
infected persons with CD4 count $200 cells/mm3 compared to
,200 cells/mm3. Although only 2% of HIV-infected persons were
on ART, we found that the odds of being IGRA positive in
persons on ART were 90% lower than those not on ART, after
adjusting for CD4 count.
Although the CD4 count, ART status and BCG scar variables
in this model had p values of .0.05, the corresponding p-value
function graphs showed that majority of data lay away from the
line of no effect. The CD4 count and BCG scar graphs were also
narrow, indicating high precision of estimates (graphs not shown).
Discussion
We examined the prevalence of latent TB infection and risk
factors that associate with TST and IGRA in HIV-infected adults
in a high HIV/TB-burden setting and interestingly these factors
differed.
TST positivity was associated with a recent TB contact history.
Few TB contact studies have been conducted in high HIV/TB
burden settings [14,15] and these support data from this study
showing a higher risk of TB infection among TB contacts with the
risk increasing with duration and intensity of exposure [15].
Predictors of Tuberculosis Infection in HIV
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Our results revealed decreased odds of IGRA positivity in
smokers compared to non-smokers. Existing literature has shown
an increased risk of TST positivity in smokers and so this finding
was unexpected [16]. Smoking is known to have immunosuppres-
sive effects and has also been shown in in vitro studies to
significantly reduce monocyte derived macrophage production of
interferon-gamma [17]. These effects combined with HIV in-
fection, although increasing the risk of TB infection, could
paradoxically result in decreased odds of IGRA positivity,
potentially limiting the performance of IGRA in HIV-infected
smokers.
We also found increased odds of IGRA positivity with more
years of education. Education was strongly associated with
employment in our data suggesting these variables may be
measuring similar exposures. The risk of LTBI is conventionally
thought to be higher in lower socioeconomic groups and several
studies conducted in high burden settings have reported increased
risk of TB with lower income [18,19]. We therefore expected
unemployment (as a marker of marginalisation and lower
socioeconomic status) to be associated with a higher risk of LTBI.
However, the data suggest the opposite. Khayelitsha is an informal
township 30km outside Cape Town and employment necessitates
travel to Cape Town using overcrowded and poorly ventilated
modes of public transport. Furthermore the force of infection in
Cape Town townships has previously been reported as being
exceptionally high [20]. One possible explanation is that TB
transmission is occurring on public transport increasing the risk of
LTBI in employed persons who use these modes of transport more
frequently and for longer distances and are potentially repeatedly
exposed. Alternatively, these results could indicate exposure to TB
from co-workers or in the general work environment, although the
majority of employment opportunities occur in more affluent parts
of Cape Town, where the TB burden is significantly lower.
There was a negative association between IGRA positivity and
the presence of BCG scar. These findings suggest a protective role
for BCG against LTBI diagnosed using IGRA. In high-burden
Table 1. Baseline characteristics stratified by TST status. TST tuberculin skin; N sample size; IGRA interferon gamma release assay;
TB tuberculosis.
Characteristics TST Negative N (%) TST Positive N (%) Total N (%)
Sex Female 130 (86.7) 139 (83.2) 269 (84.9)
Male 20 (13.3) 28 (16.7) 48 (15.1)
IGRA Negative 62 (42.2) 23 (14.0) 85 (27.2)
Positive 68 (46.3) 122 (73.9) 190 (60.9)
Indeterminate 17 (11.5) 20 (12.1) 37 (11.9)
Smoker No 131 (87.3) 144 (86.8) 275 (87.0)
Yes 19 (12.7) 22 (13.2) 41 (13.0)
Recent TB contact No 128 (85.9) 121 (74.7) 249 (80.1)
Yes 21 (14.1) 41 (25.3) 62 (19.9)
Previous TB No 123 (82.6) 146 (87.4) 269 (85.1)
Yes 26 (17.4) 21 (12.6) 47 (14.9)
BCG Scar No 61 (41.2) 82 (49.1) 143 (45.4)
Yes 87 (58.8) 85 (50.9) 172 (54.6)
Employed No 106 (70.7) 105 (63.3) 211 (66.8)
Yes 44 (29.3) 61 (36.7) 105 (33.2)
Accommodation Shack 99 (66.4) 90 (57.0) 189 (61.6)
House 50 (33.6) 68 (43.0) 118 (38.4)
Time resident in Khayelitsha ,1 year 7 (4.7) 12 (7.6) 19 (6.2)
.= 1 year 141 (95.3) 145 (92.4) 286 (93.8)
On Antiretroviral therapy No 148 (99.3) 163 (98.2) 311 (98.7)
Yes 1 (0.7) 3 (1.8) 4 (1.3)
Characteristics Median (IQR) Median (IQR) Median (IQR)
Age (years) 30.6 31.6 31
(27.5–36.9) (26.8–37.5) (26.8–37.5)
Body Mass Index (kg/m2) 27.9 26.6 26.8
(23.3–31.6) (22.6–31.3) (22.9–31.4)
Education Highest school grade achieved 11 (10–11) 11 (9–12) 11 (9–12)
Number of persons/bedroom 2 (1.67–3) 2 (1.67–3) 2 (1.67–3)
CD4 count (cells/mm3) 337 362 345
(226–476.5) (253–519) (241–504)
Number of days since HIV diagnosis 410.5 337 351
(12–1474) (25–1316) (19–1402)
doi:10.1371/journal.pone.0047072.t001
Predictors of Tuberculosis Infection in HIV
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settings, BCG vaccination is given at birth to reduce the risk of
disseminated TB in children. These results suggest that BCG also
protects against TB infection in HIV co-infected young adults.
This effect of BCG against LTBI has been reported in one study of
children with household TB contacts that reported the absence of
a BCG scar as an independent risk factor for LTBI diagnosed
using an in-house ELISpot assay [21].
Limitations
BCG vaccination status was determined using the presence of
a BCG scar. However it is possible that some participants were
BCG vaccinated but had no scars. Therefore the protective effect
of BCG might be limited to persons who scar. Another possibility
proposed by Lalvani et al is that the scarring response to BCG
could represent a surrogate marker of individuals who have pre-
existing protective immunity to tuberculosis that is not induced by
BCG vaccination [22].
The use of an in-house IGRA limits the generalisability of these
findings. Quantitative antigen responses were therefore presented
and demonstrate significantly lower responses in persons with
a BCG scar. Furthermore, an earlier comparison of this assay with
the QFT-GIT revealed an identical proportion of positive
responders suggesting comparability between these tests.
There is a possibility of bias due to misclassification of smokers.
We performed sensitivity analysis and showed that the final result
was unchanged. We however acknowledge residual confounding
as a potential limitation of this study.
Conclusion
Our data indicate an increased risk of LTBI in TB contacts
highlighting ongoing transmission in the community. The novel
finding of a higher risk of LTBI in educated and employed persons
Figure 1. Box and whiskers plots showing quantitative IGRA antigen responses (pg/ml) stratified by presence or absence of BCG
scar in the overall study population. Medians and interquartile ranges shown above each plot. Extreme values not shown.
doi:10.1371/journal.pone.0047072.g001
Table 2. Final model of risk factors associated with IGRA
positivity.
IGRA Odds Ratio 95% C.I. P-value
CD4.= 200 2.07 0.99–4.34 0.054
On ART 0.10 0.01–1.02 0.052
Highest school grade
achieved
1.19 1.05–1.34 0.005
BCG scar 0.59 0.35–1.02 0.057
Smoker 0.47 0.23–0.96 0.038
doi:10.1371/journal.pone.0047072.t002
Predictors of Tuberculosis Infection in HIV
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also suggests ongoing transmission and further research is required
to explore the contribution of public transport to high transmission
rates and the potential for public space to be targeted in the
development of TB control strategies in high-burden settings.
Smoking, as a risk factor for LTBI, is important from a public
health perspective, with up to 15% of TB cases worldwide
estimated to be attributable to tobacco exposure [23]. It is
a potentially more readily modifiable risk factor compared to other
factors that predispose to TB infection and disease and therefore
a potential target for TB control strategies. We found a lower rate
of IGRA positivity in HIV-infected smokers. This may relate to
the immunosuppressive effects of smoking and impaired in-
terferon-gamma production in HIV-infected persons, potentially
limiting the performance of this test in this sub-group. A recent
study of 1128 children in Europe showed that BCG vaccination
may be effective at protecting children against M.tb. infection [24].
We found the presence of a BCG scar to be negatively associated
with IGRA positivity suggesting a protective role for BCG
vaccination in HIV co-infected adults.
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